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Abstract
Objectives To retrospectively evaluate safety and effica-
cy of pelvic artery embolisation (PAE) in post-partum
haemorrhage (PPH) in abnormal placental implantation
(API) deliveries.
Methods From January 2009 to November 2013, 12 patients
with API and intractable intraoperative PPH underwent PAE
after caesarean delivery to control a haemorrhage (in four of
these cases after hysterectomy). Arterial access was obtained
prior to the delivery; PAE was performed in the obstetrics
operating room by an interventional radiologist that was pres-
ent with an interventional radiology (IR) team during the
delivery.
Results PAE was successful in preventing bleeding and avoid
hysterectomy in four cases (group A). Uterine atony and dis-
seminated intravascular coagulation caused failure of PAE
requiring hysterectomy in four patients (group B). PAE
prevented bleeding post-hysterectomy in the remaining four
cases (group C). Technical success (cessation of contrast ex-
travasation on angiography or occlusion of the selected artery)
was 100 %. Maternal and foetal mortality and morbidity were
0 %.
Conclusions PAE is a minimal invasive technique that may
help to prevent hysterectomy and control PPH in API preg-
nancies without complications. Embolisation should be per-
formed on an emergency basis. For such cases, an IR team on
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standby in the obstetrics theatre may be useful to prevent
hysterectomy, blood loss and limit morbidity.
Key Points
• Endovascular treatment is a validated technique in post-
partum haemorrhage.
• Abnormal placental implantation is a risk factor for post-
partum haemorrhage.
• We propose an interventional radiologist standby in the
delivery room.
Keywords Uterine Artery Embolisation . Placenta accreta .
Placenta previa . Post-partum haemorrhage . Intraoperative
procedures
Introduction
Post-partum haemorrhage (PPH) continues to cause signifi-
cant morbidity and mortality in the Western world [1]. PPH
is defined as a blood loss of more than 500 ml for vaginal
delivery or more than 1,000 ml if a caesarean section is per-
formed or as a reduction of the haematocrit higher than 10 %
during the delivery [1]. Approximately 2 % of deliveries are
complicated by PPH, and in 3 %maternal death occurs, due to
maternal age and education (years of school attendance), pre-
vious deliveries, gestational age, uterotonic drugs and anae-
mia [2]. Also, referring from another facility has shown to
correlate to severe maternal outcomes [2]. Moreover, PPH is
linked with severe morbidity: disseminated intravascular co-
agulation (DIC), respiratory distress syndrome, Sheehan’s
syndrome and hypovolemic shock may occur [3]. The main
causes of obstetric haemorrhage are: uterine atony (UA); pla-
cental abnormalities; retained placental tissue; vessel
malformations; ruptured uterus; laceration of the perineum,
vagina or cervix; non-correctable coagulopathy [4].
Abnormal placentation occurs in one of 540–70,000 deliv-
eries (mean of 1/7,000) [5]. However, these numbers are in-
creasing due to the rise caesarean deliveries. APIs are bur-
dened by a massive PPH, more than other deliveries, with a
blood loss that might exceed 5,000ml [6]. Abnormal placental
implantation (API) includes both abnormal placental attach-
ment in the lower uterine segment, overlying or near the ana-
tomical internal os of the uterus (placenta previa) and abnor-
mal uterine wall invasion (placenta accreta). According to the
depth of invasion we may recognise: placenta accreta (limited
to a superficial invasion of basalis layer), increta
(myometrium invasion) and percreta (serosa or adjacent pelvic
organs invasion).
The main risk factors for placental abnormalities are previ-
ous damage or fibrosis of the myometrium and endometrium,
such as previous caesarean sections or uterine trauma (artifi-
cial delivery, curettage, etc.), maternal age older than 35 years
or previous multiple births [7].
PPH treatment includes conservative or surgical therapy.
Surgical treatment consists in hysterectomy or uterine vessels
ligation and is associated with a significant risk of bleeding
and loss of fertility. Conservative treatments consists in the
administration of drugs that increase the tonicity of the uterus,
use of packing gauzes, haemostatic square sutures, B-Lynch
suture, insertion of Bakry balloon, and arterial embolisation
[3]. The success rates for controlling PPH are for balloon
tamponade and for pelvic devascularisation (including uterine
or internal iliac artery ligation) in the range of 85 % and for
arterial embolisation in the range of 90 % [1, 5]. The identifi-
cation of patients with API through imaging techniques [8, 9]
is of paramount importance for the prevention and treatment
of this condition. The purpose of this study is to report the
experience with our multidisciplinary protocol in the manage-
ment of massive PPH due to API and to evaluate the clinical
outcome. The protocol adopted implies an interventional ra-
diologist standby in the operating room in order to allow a
prompt embolisation in case of massive haemorrhage in hae-
modynamically unstable patients, who cannot be transferred
to the angiography suite.
Materials and methods
We collected data for this retrospective study from the clinical
records of our institution, where a mean of 2,000 deliveries are
performed every year. The study protocol was approved by
our Institutional Review Board. Inclusion criteria were (1)
presence of API that required potential vascular intervention
and (2) intractable intraoperative PPH that required immediate
embolisation in the obstetrics operating room.
A specific protocol was developed in our institution to
manage API deliveries. The protocol provides that once an
API pregnancy is identified by the gynaecologist, the inter-
ventional radiology unit may be alerted. The obstetric operat-
ing room is prepared for both surgical and embolisation pro-
cedures. The interventional radiologist may be standing by
during delivery in the operating room, so as to be prompt to
attend PAE.
Between January 2009 and November 2013, a total of 76
patients with imaging-confirmed diagnosis (magnetic reso-
nance imaging [MRI] or ultrasound) of API were managed
with our protocol for API deliveries. A 5-F introducer sheath
was positioned in the common femoral artery in the angio-
graphic suite at least 2 h before prior to the delivery [8]. An
informed consent for embolisation was obtained from all the
patients at this stage. A portable angiographic (OEC-9800; GE
Healthcare, Milwaukee, WI, USA) system and an emergency
angiographic tray were transferred to the obstetrics operating
room and the interventional radiologist was on standby. Pelvic
artery embolisations (PAEs) were performed by one of three
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interventional radiologists with 10–30 years of clinical expe-
rience, and at least 5 years of experience of our protocol.
Twelve of these 76 patients, experienced an intractable in-
traoperative PPH after caesarean delivery and underwent PAE
to control a massive haemorrhage were enrolled in this study.
Patient’s characteristics and risk factors are shown in Table 1
and pre- and post-procedure information in Table 2.
The indication to PAE was the development a severe PPH
not responding to conservative manoeuvres, causing a life-
threatening blood loss with hemodynamic consequences,
needing unusual therapy [10]. The decision on whether to
proceed to PAE before the hysterectomy or not was decided
by the obstetrician surgeon for each individual case, after a
prompt consult with the anaesthesiologist and the interven-
tional radiologist in the operating room. Usually, patients were
initially treated with uterotonic drugs and obstetric manoeu-
vres including:massage of the uterus, packing gauze andman-
ual exploration of the uterine cavity. Once conservative ma-
noeuvres failed to control haemorrhage most patients
underwent balloon tamponade and suturing (B-Lynch and
squared sutures). If bleeding was not controlled, decision for
hysterectomy or PAE was made according to operator’s pref-
erence; PAE was performed for patients that were haemody-
namically unstable (systolic blood pressure lower than
90 mm/Hg and heart rate greater than 120 beats/min despite
adequate medical management or the need for continuous
administration of a vasopressor). Initially, pelvic angiograms
were obtained to identify the uterine artery and the other po-
tential sites of bleeding from the pelvic arteries (Fig. 1). Se-
lective catheterisations were performed using 4- to 5-F cathe-
ters with different shapes (Cobra, RIM or RC2 catheter;
Cordis, Miami, FL, USA) and an 0.035^ hydrophilic guide
wire (Glidewire; Terumo Europe, Leuven, Belgium). Emboli-
sation was performed with the use of gelatine sponge particles
(Spongostan; Ferrosan, Søborg, Denmark) and 4- to 10-mm
coils (MReye; Cook, Bloomington, IN, USA).
In all cases, the embolisation was performed on at least one
uterine or anterior division of the internal iliac artery; addi-
tional arteries were embolised only when identified as the
bleeding foci. Technical success was defined as angiograph-
ically successful target vessel occlusion after embolisation.
Embolisation was either performed according to contrast ex-
travasation or in the case of no visible extravasation, empiri-
cally as previously described [11] and following the indication
of the obstetric surgeon that observing the surgical field guid-
ed the interventional radiologist to embolise the right or left
side.
The parameters that were analysed were: number of
embolised vessels, type of embolic agents used, intraoperative
blood loss and supportive fluids (blood, crystalloids and col-
loids as plasma expander, saline solution, potassium chloride,
lactated Ringer’s, albumin) used, blood haemoglobin before
and after the procedures, complications associated with the
PAE procedure. Data were expressed as mean±standard devi-
ation (SD), fractions, and percentages. The Mann-Whitney U
test was used to test for significant differences between con-
tinuous variables. Statistical analysis was performed using
MedCalc software (versionMedCalc 12.5.0.0; MedCalc Soft-
ware, Ostend, Belgium). Clinical success was defined as the
ability to avoid hysterectomy applying the interventional
standby protocol.
Complications from procedures were classified according
to guidelines established by the Society of Interventional Ra-
diology (SIR) Standards of Practice Committee [12].
Table 1 Patients’ characteristics
Patient
number
Age Previous
pregnancies
Miscarriage Voluntary
pregnancy
interruption
Curettage Previous
caesarean
deliveries
Previous
vaginal
deliveries
Endometriosis Primiparous API Diagnosis
API pre-
post
delivery
(US/MRI)
1 36 1 - 1 - - - No Yes Previa US + MRI Group
A2 36 3 1 - 1 2 - No No Previa US
3 37 2 1 - 1 1 - No No Previa US + MRI
4 33 6 - 2 - - 4 No No Previa US
5 31 4 - 3 - 1 - No No Accreta US + MRI Group
B6 32 2 - 1 - 1 - No No Previa US
7 41 1 1 - - - - No Yes Previa US + MRI
8 36 - - - - - - Yes Yes (twin) Previa US
9 40 4 4 - 2 - - No Yes (twin) Accreta US Group
C10 38 2 1 - - 1 - No No Accreta US
11 38 2 1 - - 1 - No No Percreta US + MRI
12 30 4 - - 2 1 1 No No Increta US + MRI
API abnormal placental implantation, US ultrasound, MRI magnetic resonance imaging
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Results
Seven patients had placenta previa, three placenta accreta, one
placenta increta and one placenta percreta were included in the
study. The mean intraoperative blood loss was 2,389 ml. The
mean blood haemoglobin (Hb) before the delivery was
10.77 g/dl and dropped to 6.27 g/dl during the delivery. Sup-
portive therapy consisted in a mean infusion of 3,688 ml of
crystalloid and colloids, and 1,739 ml of blood transfusion;
uterotonic drugs were given to all patients. A statistically sig-
nificant difference (p value=0.0183) was detected between
the mean estimated intraoperative blood loss in placenta
previa (1,710±513 ml) and placenta accreta (3,340±1,
264 ml). No statistically significant difference was detected
among blood or fluid infusion in the two subgroups. Results
are shown in detail in Table 3.
In 8/12 patients contrast extravasation was confirmed, in-
dicating active haemorrhage. In four of the 12 cases the PAE
was performed unilaterally and a total of 24 arteries were
embolised: 14 uterine arteries, 1 inferior epigastric artery and
9 anterior division of the internal iliac arteries (Table 4). We
used gelatine sponges in all cases, injecting piecemeal with
cutting sponges; coils were also used in eight cases.
PAE was able to control the haemorrhage in four cases,
avoiding hysterectomy (group A; Table 1). In four cases the
PAE was not able to control haemorrhage and to prevent the
hysterectomy (group B), and in one of these a second embo-
lisation session was necessary to control the haemorrhage (pa-
tient 8). Patient 8, as well as patient 7, despite a successful first
embolisation of left uterine artery, experienced a UA and
underwent hysterectomy. A persistent bleeding was identified
in the Pouch of Douglas of patient 8 after hysterectomy, prob-
ably due to a severe endometriosis, and a second embolisation
of anterior division of the internal iliac arteries was necessary
after 30 min from the first embolisation. In four patients
(group C) the initial decision was to undergo the
Fig. 1 Massive haemorrhage. Patient 5, right uterine catheterisation
showing a massive contrast extravasation (arrow) from the body of
uterus; the left uterine artery is visible, suggesting bleeding also from
this side (black arrowhead)
Table 3 Results
Haemoglobin (mean)
Before delivery 10.77 g/dl (min 8.5-max 12)
Before PAE and hysterectomy 6.27 g/dl (min 4.8-max 8.1)
24 h after the procedures 10.05 g/dl (min 7.7-max 12.7)
72 h after the procedures 9.9 g/d (min 8.3-max 11.9)
Colloid/crystalloid infusion (mean) 3,688 ml (min 1,500-max 6,100)
Blood infusion (mean) 1,739 ml (min 300-max 3,700)
Intraoperative blood loss (mean) 2,389 ml (min 1,200-max 5,000)
Previa (n=7) Accreta (n=5) p value
Blood infusion (mean) 1,021±595 ml 2,722±2,999 ml 0.4649
Colloid/crystalloid infusion (mean) 3,157±1,975 ml 4,430±1,885 ml 0.2556
Intraoperative blood loss (mean) 1,710±513 ml 3,340±1,264 ml 0.0183
WBC increase 8 patients
Fever 5 patients
Elapsed time (delivery-menses) 4 months
Procedure time 38 min (min 19-max 61)
WBC white blood cells, PAE pelvic artery embolisation
Eur Radiol
Table 4 PAE procedure details
Patient
number
Coils Spongostan Angiographic
contrast
pooling
Embolisation
of uterine
artery
Embolisation of anterior
division of internal iliac
artery
Embolisation of
epigastic artery
Necessity of hysterectomy
(pre or post embolisation)
1 No Yes Yes R and L No Group
A2 No Yes Yes R No
3 Yes Yes No R a No
4 Yes Yes Yes R a and L a No
5 Yes Yes No R a Yes: post-emb Group
B6 No Yes No R and L R and L Yes: post-emb
7 Yes Yes Yes L a R Yes: post-emb
8 Yes Yes Yes L R a and L a Yes: post-emb (PAE
performed also after
hysterectomy)
9 No Yes Yes R and L Yes: pre-emb Group
C10 Yes Yes Yes R a and L a R a Yes: pre-emb
11 Yes Yes No R a and L a Yes: pre-emb
12 Yes Yes Yes L a Yes: pre-emb
R right, L left
a Embolised by coil
Fig. 2 Bilateral uterine artery
coiling. Patient 11: selective
catheterisation of the left uterine
artery and angiography post
subtotal hysterectomy without
evidence of contrast
extravasation (a); super-selective
catheterisation with microcatheter
of the left uterine artery and
release of coils (arrow); the
angiogram shows the complete
occlusion of the uterine artery;
note the intra-abdominal surgical
gauzes that hinder the
angiographic visualisation
(asterisk) (b); right internal iliac
catheterism with no evidence of
bleeding (c); due to a persistent
haemorrhage the right uterine
artery was embolised with
absorbable gelatine sponge and
coils (arrow) (d)
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hysterectomy; however, bleeding was not controlled, there-
fore PAE was retained as the last resort for haemostasis. In
these patients the radiologist and the surgeon, in accord with
the anaesthesiologist, decided to attempt the hysterectomy im-
mediately, thus because of the sudden onset of haemorrhage
and the profuse blood loss. In patient 11 a persistent bleeding
was observed from cervical arteries; after that, a subtotal hys-
terectomy was necessary because a uterine fibroid hampered
clamping the uterine arteries, so PAE was performed on the
cervical uterine arteries (Fig. 2). Even patient 12 with an
increta placenta developed a bleeding from the cervix arteries
after a subtotal hysterectomy requiring PAE. In patient 10 the
hysterectomy was immediately performed because of a mas-
sive bleeding of vescico-uterine pouch; then an adnexal bleed-
ing was observed causing DIC, so embolisation of the anterior
division of internal iliac arteries and of the right inferior epi-
gastric (Fig. 3) were performed.
The technical success rate of embolisation (among all
groups) was of 100 %, accompanied by a clinical success of
33 %, defined as the ability to avoid hysterectomy applying
the interventional standby protocol. Foetal and maternal mor-
tality was of 0 %. Twenty-four and 72 h after the procedures
the meanHb improved to 10.05 and 9.9 g/dl, respectively. The
embolisation procedure lasted an average of 38 min (range,
19-61 min), with a mean fluoroscopy time of 11 min. Eight
patients had a rise in white blood cells and five had fever after
the procedure. No transient or persistent ovarian failure was
noted at follow-up. Regarding the SIR classification [12] no
minor or major complications due to embolisation, were noted
after the procedure. All patients who did not undergo hyster-
ectomy experienced regular menses at a mean of 4 months
after delivery, but none had new pregnancies.
Discussion
The early identification of placental abnormalities is essential
to avoid risk of mortality and morbidity associated with deliv-
ery [2]. In all patients of our series the diagnosis was suspected
by symptoms and risk factors; abnormalities were identified
by ultrasound and MRI and confirmed by histopathology
analysis. Surgical hysterectomy is still the first choice treat-
ment of API deliveries complicated by PPH [13]. However,
PAE in PPH showed promising results in several studies, with
good bleeding control and few complications [13, 14]. PAE is
a suitable alternative to hysterectomy because it allows a bet-
ter control of bleeding, blocking also small haemorrhage foci,
and gives the possibility of preserving fertility, avoiding major
surgery and general anaesthesia.
The role of PAE in API deliveries remains unclear due to a
high risk of failure (up to 50 %) [4]; multiple risk factors are
involved, such as myometrial injury during vaginal delivery,
Fig. 3 Coiling of right inferior epigastric and internal iliac arteries.
Patient 10: selective catheterisation of left internal iliac artery showing a
faint contrast pooling in the cervical branches of uterine artery (head) (a);
angiogram of the right internal iliac artery; note the coiling of the anterior
branch of the anterior division of the left internal iliac artery (arrow) (b);
angiogram with pig tail in the aorta showing occlusion of the bilateral
anterior division of internal iliac arteries (arrows); note the reduced
diameter of right external iliac artery (spasm) due to persistent
haemorrhage (c); selective catheterisation of the right inferior epigastric
artery with angiogram showing contrast extravasation (asterisk) (d);
coiling in the right inferior epigastric artery (arrowhead) and in the
anterior branch of internal iliac arteries (e)
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placental removal, DIC, incomplete embolisation of the arter-
ies due to an insufficient ability in identifying bleeding foci
[15].
Despite the development of new tools and catheterisation
techniques, the improvement of supportive and conservative
care procedures, few articles have reported successful treat-
ment of PPH in API deliveries with success rates up to 90 %
[16, 17]. However, in the aforementioned reports, patients did
not have massive bleeding; in fact, the authors were able to
transfer the patients in the angiographic suite. In our series, all
patients had a massive haemorrhage and haemodynamic in-
stability not responding to supportive care and other conser-
vative manoeuvres.
In group C, PAE was performed for a persistent haemor-
rhage after hysterectomy, achieving technical success and
bleeding control. The persisting bleeding probably was due
to the onset of DIC and caused a worsening of haemodynamic
parameters and patients’ conditions. Moreover, finding the
haemorrhagic focus and performing vascular ligations of
small pedicles after hysterectomy in such patients could be
extremely difficult for the surgeon [18]. All these causes of
persistent bleeding after hysterectomy support the usefulness
of PAE after hysterectomy to reduce maternal mortality, even
if reports in the literature are still few.
In group B, PAE allowed a safer and easier hysterectomy to
be performed, although it was clinically unsuccessful: reduc-
ing bleeding, making the field bloodless, improving the pos-
sibility of the surgeon to identify the pelvic structures, as well
as aiding to avoid DIC. Blood loss and the type of placentation
abnormality seem to correlate with the possibility of preserv-
ing the uterus. In fact, it is interesting to note that all the
patients of group C and one of group B had a placenta accreta
and were not able to avoid hysterectomy. All the patients of
group A suffered from placenta previa and were successfully
managed with PAE only. Moreover, placental accretism was
associated with a significantly higher estimated intraoperative
blood loss than placenta previa (Table 3).
UA and DIC are the most threatening PPH complications
that could affect the success of embolisation. In case of UA,
the absence of myometrial contraction does not allow the oc-
clusion of spiral arteries of endometrium; compressive sutures
and Bakry balloon are often not sufficient to compress arteries
of the fundus of uterus, and the PAE cannot stop bleeding
from all foci, even if there is no evidence of active pooling.
Moreover, vascular spasm in the shock or impending shock
due to massive blood loss could cause PAE failure because it
hampers the selective vascular catheterisation and the delivery
of embolic agents to the bleeding focus [17]. Contrast pooling
was visible in eight cases (67 %); in the remaining four pa-
tients (33 %), no active contrast medium extravasation was
visible, probably due to vascular spasm or hypotension. In
these cases, we opted for a unilateral or bilateral (performed
in 7 of 12 patients; 58 %) embolisation of uterine artery or
anterior division of internal iliac artery according to the ob-
stetric surgeon indications that are essential to identify the
bleeding site; observing the surgical field, the surgeon could
guide the interventional radiologist to embolise the right or left
side.
In only one case did we find an unusual site of bleeding
(patient 10) from the right inferior epigastric artery. In this
case probably the presence of CID associated with a trauma-
tism by surgical retractor caused the artery damage. Another
potential source of bleeding is the ovarian artery. The inter-
ventional radiologist should be aware of this possibility, espe-
cially in the case of persistent bleeding after uterine or anterior
division branch of internal iliac artery embolisation and a
juxtarenal arteriography should be performed to exclude
blood supply from these arteries [18, 19].
Many embolisation agents were described as useful agents
performing PAE and other uro-genital and pelvic intervention-
al procedures [20, 21]. Absorbable gelatine sponge is the em-
bolic material of choice because of its ease of delivery and
duration of effect [22]; nevertheless, it might be insufficient
due to hypervascularisation [16, 17]. Some authors recom-
mend the use of absorbable sponge as first choice absorbable
embolic agent and PVA in case of failure with sponge alone
[23]. In all cases, we attempted to achieve success with ab-
sorbable gelatine sponge only (Fig. 4). Since the speed of
stopping bleeding is paramount in patients with such a mas-
sive acute bleeding and haemodynamic instability, we associ-
ated metallic coils in 67 % of patients to achieve a prompt
technical success. In patients in whom hysterectomy would
be avoided (groups A and B) coils were used as the last chance
to achieve procedure success. We preferred to avoid small-
sized particles because they could cause necrosis and distal
occlusions due to permanent ischaemia. The use of PVA (size
range from 150 to 1,200 μm) particles is not recommended as
they may cause uterine necrosis. Moreover, micro-particles
may pass through arteriovenous shuntings due to accretism
and cause distal dissemination [24]. Other authors recommend
NBCA glue (N-butyl cyanoacrylate) as embolic agent, to have
a definitive occlusion of arteries; hence, NBCA should be
considered for definitive devascularisation as well as coils.
This embolic agent should be used particularly when the
bleeding derives from pseudoaneurysm or lacerated arteries
because has demonstrated effectiveness in such indications
[10, 25]. In our series, no patient underwent ovarian insuffi-
ciency or uterine/bladder necrosis. Some authors suggest the
use of balloons catheters positioned in the common iliac arter-
ies before the procedure, to control bleeding after delivery
[26]. With this procedure the ischaemic risk increases; indeed
some authors reported a lower-limbs ischaemia [26].
Prophylactic balloon occlusion of the pelvic arteries was
proposed by several authors in the management of PPH, es-
pecially in the API subgroup and showed to be an effective
technique [27, 28]. Balloons are usually placed before the
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delivery in the iliac common artery, in the internal iliac artery
or in its anterior division [27, 28]; some authors reported a
temporary occlusion of the abdominal aorta distally to renal
arteries [29]. Evidence suggest that positioning the balloon in
the common iliac arteries should be preferred in the elective
setting [27], while infrarenal aortic occlusion should be re-
served for the acute setting, which proved safe even when
occlusion lasted up to 80 min [29]. Balloon occlusion effec-
tiveness did not show to be more effective than PAE [1, 5];
moreover, it provides preventive treatment of all the patients
with a consequent increase in costs and risks.
Patient transfer from the obstetric suite to the angiographic
one could be an issue because it variably increases morbidity
and mortality [30], and, above all, is unsafe in haemodynam-
ically unstable patients. Several complications could occur
during transfer, such as cardio-respiratory events or equipment
failure. In fact, the American College of Obstetricians and
Gynecologists (ACOG) guidelines recommended the use of
embolisation only in haemodynamically stable patients when
the rate of loss is not excessive [1]. However, the possibility of
performing embolic procedures without patient transfer is be-
coming popular in many cardiovascular or neurovascular [31,
32] as well as in obstetric procedures [33].
Prophylactic catheterisation with intraoperative embolisa-
tion, compared with emergency vascular access and emboli-
sation in the angiography room allows a significant reduction
of the delay between the onset of bleeding and the
embolotherapy. In our series the mean blood loss was consid-
erably less with respect to the value reported in the literature
(2,389 ml vs 4,500 ml) [6], although hysterectomy cannot be
avoided in all cases. According to the literature, accretism has
a statistically significant influence on the estimated blood loss
only [6]. Some authors suggest considering PAE or surgical
ligation of uterine arteries within 30-60 min from failure of
other approaches [34]. The portable angiographic system and
the emergency angiographic tray allows operation on
haemodynamically unstable patients, not only stable ones,
because of the impossibility to move these high-risk patients
to the angiographic suite or to another hospital [35].
Maternal fertility can be preserved after uterine embolisa-
tion and multiple new pregnancies have been reported after
embolisation [36]. The hysterectomy rate after caesarean de-
livery, reported in the literature, can vary from 5 % [37],
among placenta previa, up to 23-35 % in placenta accreta
[38]. Only the 10 % (eight patients; groups B and C) of the
76 patients managed with our protocol required hysterectomy.
In our series, 4 of 12 patients avoided hysterectomy, resulting
in a clinical success of 33 %; none of these four patients, who
did not undergo a hysterectomy, had a new pregnancy at a
mean follow-up time of 3.6 years, but all of them experienced
regular cycles. Moreover, one patient underwent a
salpingectomy, due to the patient’s wish for sterilisation. No
minor or major complications due to embolisation were noted.
Caesarean delivery is usually accompanied by increased
WBC and fever, and did not cause any difference in patients’
care, so we did not consider these signs as a procedure
complication.
This study has several limitations: the small number of
patients enrolled at one institution; the retrospective nature
of the study. The small number of patients does not allow a
proper comparison with other protocols, thereby preventing to
understand the true value of IR standby. Moreover, perfor-
ming PAE in the obstetric suite with the portable angiographic
C-arm is burdened by some technical limitations. Firstly, there
are many surgical tools in the field of view; secondly, com-
pared with the angiographic suite, the absence of the mobile
table and the reduced field of view do not allow an optimal
visualisation of the operating field.
Applying our protocol, joined by the obstetrical and radio-
logical department, foreseeing the intervention in the operat-
ing room of an interventional radiologist with mobile equip-
ment, maternal and foetal mortality of massive PPH in API
Fig. 4 Embolisation with
absorbable sponge. Patient 1: left
internal iliac artery angiogram
before (a), and after (b)
embolisation with an absorbable
gelatine sponge showing
complete occlusion of the anterior
division; PAE avoided
hysterectomy in this patient
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deliveries was reduced to zero. Moreover, hysterectomy was
avoided in four patients suffering from placenta previa, pre-
serving their menses and potentially their fertility.
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